CHE
Chemed Corporation · Healthcare · Medical - Care Facilities
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +0.6% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | +1 | 53.78K | $26.72M | +1 | −1 |
| Q2 2026 | 131 | +6 | 8.89M | $4.13B | +9 | −4 |
| Q1 2026 | 129 | 0 | 8.71M | $3.29B | +5 | −6 |
| Q4 2025 | 129 | -2 | 9.90M | $4.23B | +1 | −2 |
| Q3 2025 | 22 | -1 | 5.87M | $2.63B | n/a | −2 |
| Q2 2025 | 21 | +1 | 4.75M | $2.31B | +2 | −1 |
| Q1 2025 | 17 | 0 | 1.55M | $954.33M | +1 | −1 |
| Q4 2024 | 17 | +1 | 1.54M | $817.61M | +2 | −1 |
| Q3 2024 | 15 | 0 | 874.91K | $525.85M | n/a | n/a |
| Q2 2024 | 15 | n/a | 976.21K | $529.86M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 485.10K | +1.0% | $298.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 355.98K | +4.6% | $219.09M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passief) | 200.75K | +10.9% | $123.53M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Point72 Asset Management ✦ | 128.68K | +24.9% | $79.18M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 77.06K | -4.5% | $46.81M | 0.0% | ▼ Trim | 4 | SEC ↗ ×5 |
| 6 | Millennium Management ✦ | 71.87K | -49.0% | $44.22M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 51.10K | +8.5% | $31.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 48.29K | -37.4% | $29.71M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 9 | D. E. Shaw & Co. ✦ | 43.65K | +874.3% | $26.86M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 10 | T. Rowe Price ✦ | 22.82K | -9.8% | $14.04M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 11 | GAMCO Investors ✦ | 19.91K | -6.5% | $12.25M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 12 | Gotham Asset Management ✦ | 14.95K | -6.6% | $9.20M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 11.48K | +43.8% | $7.07M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 7.67K | -8.2% | $4.72M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 6.80K | Nieuw | $4.19M | 0.0% | New | 1 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 3.72K | -29.9% | $2.29M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Wellington Management ✦ | 2.01K | -10.2% | $1.24M | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Arrowstreet Capital | $4.19M | 0.0% |
Verlaten
| Marshall Wace | $618,276 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 486 houders, 12.67M aandelen, $4.47B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer, Director · 2.00K aand · $1.03M
Officer, Director · 2.00K aand · $1.00M
Officer, Director · 2.00K aand · $1.08M
Officer · 1.00K aand · $541,040
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie